A novel 21‐kDa protein as a serum marker for benign and malignant urogenital tumors: Preliminary communicationChanna Shalitin, Eliezer Robinson, Ruth Segal et al.|International Journal of Cancer|1991Cited by 6
ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR THE DETECTION OF A NOVEL 21-KDA PROTEIN ASSOCIATED WITH THE CLINICAL COURSE OF PATIENTS WITH UROGENITAL TUMORSChanna Shalitin, M LERNER, Ron Epelbaum et al.|International Journal of Oncology|1992Cited by 3
The significance of a 21 kDa protein serum levels in the follow-up of patients with renal cell carcinoma after radical nephrectomyRon Epelbaum, Channa Shalitin, Ofer Nativ et al.|European Journal of Cancer|1993Cited by 0